CRIS Current Research Information System

N/A

Paes, B., Lanari, M., Rodgers-Gray, B., Fullarton, J., Carbonell-Estrany, X. (2024). Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants. FRONTIERS IN PEDIATRICS, 12, 1-6 [10.3389/fped.2024.1343960].

Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants

Lanari, Marcello
Secondo
Writing – Review & Editing
;
2024

Abstract

N/A
2024
Paes, B., Lanari, M., Rodgers-Gray, B., Fullarton, J., Carbonell-Estrany, X. (2024). Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants. FRONTIERS IN PEDIATRICS, 12, 1-6 [10.3389/fped.2024.1343960].
Paes, Bosco; Lanari, Marcello; Rodgers-Gray, Barry; Fullarton, John; Carbonell-Estrany, Xavier
1.01 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
fped-12-1343960.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 240.63 kB
Formato Adobe PDF
Visualizza/Apri
240.63 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/959854
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact